Vandetanib

• Description:

  Vandetanib is an orally bioavailable 4-anilinoquinazoline. Vandetanib selectively inhibits the tyrosine kinase activity of vascular endothelial growth factor receptor 2 (VEGFR2), thereby blocking VEGF-stimulated endothelial cell proliferation and migration and reducing tumor vessel permeability.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  475.31

• Molecular Formula:

  C22H24BrFN4O2

• Notes:

  Research use only, not for human use.

• Receptor:

  EGFR| VEGFR2| VEGFR3

• CAS Number:

  443913-73-3